Correction to: British Journal of Cancer (2019) 121, 659–665; https://doi.org/10.1038/s41416-019-0559-6; published online 6 September 2019.
The original version of this article contained an error in Figs. 3i, j. The key for each should read CD4 High + FOXP3 High, CD4 High + FOXP3 Low, CD4 Low + FOXP3 High, CD4 Low + FOXP3 Low. The corrected figure is below. The interpretation of the data and conclusions are not affected.
Fig. 3
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kuwahara, T., Hazama, S., Suzuki, N. et al. Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer. Br J Cancer 121, 983–984 (2019). https://doi.org/10.1038/s41416-019-0605-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-019-0605-4
This article is cited by
-
Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
Scientific Reports (2021)
-
Identification of Significant Genes and Pathways in Acute Pancreatitis via Bioinformatical Analysis
Digestive Diseases and Sciences (2021)
